Cite
Predictive role of sustained imaging MRD negativity assessed by diffusion-weighted whole-body MRI in multiple myeloma.
MLA
Belotti, Angelo, et al. “Predictive Role of Sustained Imaging MRD Negativity Assessed by Diffusion-Weighted Whole-Body MRI in Multiple Myeloma.” American Journal of Hematology, vol. 98, no. 9, Sept. 2023, pp. E230–32. EBSCOhost, https://doi.org/10.1002/ajh.26995.
APA
Belotti, A., Ribolla, R., Crippa, C., Chiarini, M., Giustini, V., Ferrari, S., Peli, A., Cattaneo, C., Roccaro, A., Frittoli, B., Grazioli, L., Rossi, G., & Tucci, A. (2023). Predictive role of sustained imaging MRD negativity assessed by diffusion-weighted whole-body MRI in multiple myeloma. American Journal of Hematology, 98(9), E230–E232. https://doi.org/10.1002/ajh.26995
Chicago
Belotti, Angelo, Rossella Ribolla, Claudia Crippa, Marco Chiarini, Viviana Giustini, Samantha Ferrari, Annalisa Peli, et al. 2023. “Predictive Role of Sustained Imaging MRD Negativity Assessed by Diffusion-Weighted Whole-Body MRI in Multiple Myeloma.” American Journal of Hematology 98 (9): E230–32. doi:10.1002/ajh.26995.